Skip to main content
NewslettersWatchlist

Cardinal Health(CAH-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low113.65
Day High116.54
Open:116.10
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
Stocks Finish Higher on Strength in Tech Earnings
Barchart
Stocks Supported by Strong Amazon and Intel Earnings
Barchart
Stocks Jump on Solid Amazon Earnings and Dovish US Payroll Report
GlobeNewswire
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
Barchart
Stocks Close Little Changed Ahead of Wednesday’s FOMC Decision
Barchart
Stocks Finish Mostly Lower Ahead of Friday’s US Payroll Report
Barchart
Stocks Slip on Mixed US Economic News
MarketBeat
Cardinal Health Soars as America’s Leading Acute Care Supplier
Barchart
Stocks Muted Before the Open as Investors Await U.S. Economic Data and Fed Speak, Walmart Earnings on Tap
Barchart
Stocks Finish Higher on a Fed-Friendly US July CPI Report
Barchart
Stocks Turn Mixed as Support from July CPI Report Fades
Barchart
Stocks See Support from Favorable July CPI Report
Barchart
Stock Index Futures Tread Water as Key U.S. Inflation Data Looms
Barchart
S&P 500 and Nasdaq 100 Post Record Highs on Fed Rate Cut Hopes
Barchart
Stocks Supported as Weak US Economic News Bolsters Hopes for Fed Rate Cuts
Barchart
Stocks Settle Higher on Q1 Earnings Optimism
Barchart
Stocks Soar with Earnings on Tap
Barchart
Stocks Push Higher Ahead of Megacap Tech Earnings
Barchart
Stocks Slump as Fed Signals No Rush to Cut Interest Rates
Barchart
3 Healthcare Stocks Ready to Soar in 2024
Barchart
Stocks Drop as Strong U.S. Economic News Curbs Fed Cut Expectations
The Globe and Mail
Hostilities resume in Aimia takeover battle after OSC hearing delivers mixed result

Profile

Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.'

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.